Life Technologies traces its roots back to 1962 with the creation of Grand Island Biological Company (GIBCO) in Grand Island, New York, making serum harvested from horses raised on their land.
The original Life Technologies, Inc. (LTI), a subsidiary of Dexter Corp., was founded in 1983 by the merger of Bethesda Research Laboratories, Inc. (BRL) and GIBCO Corporation. Life Technologies was bought out by the smaller, cash-rich Invitrogen in 2000, who gradually discontinued the use of the name Life Technologies.
The new Life Technologies Corp. (NASDAQ: LIFE) was formed November 21, 2008 with the completion of the merger of Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:AB) Applied Biosystems. The company elected to resurrect the Life Technologies name for which it still held the trademark.
Applied Biosystems (formerly GeneCo) was founded in 1981 by Sam Eletr and Andre Marion as a biochemical and manufactured diagnostic research instrument manufacturer. Perkin Elmer acquired Applied Biosystems in 1983 and held it until 2000 when it was released as a publicly traded company. The former parent Perkin Elmer then became Applera. By 2002, Applied Biosystems reached revenues of $1.6 billion and maintained a variety of products including the SOLiD System - a next-gen DNA sequencing platform.
Lyle Turner, Joe Fernandez and William MacConnell (who was later bought out) founded Invitrogen in September 1987. They focused on developing products for the niche within the molecular biology research market for kits, reagents and services. They advertised in scientific journals, catalogs and everywhere they thought scientists would scan. Within three months, they sold their first kit, The Librarian, for $3,200. In 1998, Invitrogen offered more than 2,000 products. Invitrogen’s initial public offering (IPO) was made in February 1999 and raised $48.1M.
Life Technologies Timeline
- 2010 – GIBCO launches Gibco® CD FortiCHO™ medium
- 2010 – Life Technologies acquires Acrometrix, a provider of molecular and serological diagnostic quality control products to clinical laboratories, blood screening centers and in-vitro diagnostic (IVD) manufacturers.
- 2010 – The AmpFℓSTR® MiniFiler™ PCR Amplification Kit is approved for inclusion in the National DNA Index System
- 2000 – Invitrogen bought Dexter Corporation, owner of the original Life Technologies.
- 2000 – Invitrogen merges with Life Technologies, one of the longest standing companies in the industry and a world leader in molecular biology and cell culture supplies for the life science industry. Combined, the new company has a technology portfolio of more than 200 issued and pending patents and more than 300 licenses.
- 1993 – GIBCO becomes the world’s largest collector of Fetal Bovine Serum (FBS)
- 1993 – GIBCO sites in New York, Scotland and New Zealand certified as ISO-9001 compliant.
- 1994 – Liquid Media Concentrate technology from GIBCO first used in large-scale production.
- 1981 – First embryonic stems cells cultured at GIBCO
- 1982 – GIBCO licenses the first human insulin recombinant protein as a therapeutic agent.
- 1975 – Production of monoclonal antibodies are invented by Cesar Milstein and Georges J.F. Kohler of GIBCO.
- 1962 – Grand Island Biological Company (Gibco) is founded in Grand Island, New York. The company supplied serum harvested from horses raised on their own land.
- 1964 – GIBCO cultures the first stem cells.
- 1965 – Serum and dry powder media production are combined at the GIBCO facility.